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Abstract Ca2+ chelating agents are widely used in biological
research for Ca2+ buffering. Here we report that BAPTA,
EDTA and HEDTA produce fast, reversible, voltage-dependent
inhibition of swelling-activated Cl3 current (ICl;swell) in LNCaP
prostate cancer epithelial cells that is unrelated to their Ca2+
binding. BAPTA was the most effective (maximal blockade
67%, IC50 = 70 WM, at +100 mV) followed by EDTA and
HEDTA. ICl;swell blockade by EDTA was pH-dependent.
BAPTA blocked ICl;swell also in other cell types. We conclude
that Ca2+ chelating agents block ICl;swell by acting directly on
the underlying channel, and that the negative charge of the free
chelator form is critical for the blockade. 4 2002 Published by
Elsevier Science B.V. on behalf of the Federation of European
Biochemical Societies.
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1. Introduction
Ca2þ is a universal second messenger regulating many cel-
lular processes and a number of ion channels. The special
regulatory role of this vital and most abundant divalent mac-
ro-element is realized via its ability to form high a⁄nity co-
ordination bonds with various anionic groups of the proteins
lowering its e¡ective regulatory concentrations well below mi-
cromolar levels. Therefore, identi¢cation of high a⁄nity Ca2þ
regulatory sites and uncovering their physiological roles often
requires the use of Ca2þ chelating agents (EGTA, EDTA,
BAPTA, etc.) in order to permit su⁄cient lowering and con-
trolled manipulation of its concentration. Traditionally Ca2þ
chelating agents were considered to be neutral producing ef-
fects only via changing free Ca2þ concentration. Since phys-
iological Ca2þ concentrations inside the cell ([Ca2þ]in) are
within the submicromolar range, which is at least 1000 times
lower than outside, the most common use of Ca2þ chelating
agents is to bu¡er free Ca2þ concentrations ([Ca2þ]free) in
arti¢cial intracellular salines. However, experimental needs
often require lowering the extracellular Ca2þ concentrations
([Ca2þ]out) as well. As far as Ca2þ regulation of membrane ion
channels is concerned, the brightest example of the productiv-
ity of this approach was the discovery of Ca2þ-dependent
permeability switch of voltage-gated [1,2] and store-operated
Ca2þ channels (SOCs) [3,4] resulting in their ability to pass
huge Naþ current under conditions of submicromolar extra-
cellular Ca2þ.
Volume-regulated anion channels (VRACs), which carry
swelling-activated Cl3 current (ICl;swell), are widely represented
in many cell types, where they play a key role in regulatory
volume decrease [5^7]. We have recently described VRAC-
carried ICl;swell in the human prostate cancer epithelial cell
line LNCaP (lymph node carcinoma of the prostate) [8],
and showed its susceptibility to the regulation by Ca2þ enter-
ing the cell via plasma membrane SOCs [9]. Here, by focusing
on possible modulation of ICl;swell in LNCaP cells by submi-
cromolar concentrations of extracellular Ca2þ we unexpect-
edly discovered that Ca2þ chelating agents, such as BAPTA,
EDTA and HEDTA, used to bu¡er [Ca2þ]out, are themselves
capable of inducing voltage-dependent ICl;swell inhibition. This
inhibition appeared to be not restricted to LNCaP cells, but
characteristic of all VRACs in general irrespective of their
cell-speci¢c phenotypic representation. Our data suggest the
existence in VRAC of an interaction site with Ca2þ chelating
agents and prompts careful selection of the type and concen-
tration of the chelator for Ca2þ bu¡ering purposes.
2. Materials and methods
The procedures of LNCaP cells (American Type Culture Collec-
tion) culturing and preparing them for electrophysiology are detailed
elsewhere [8]. Macroscopic membrane currents were recorded using
the patch-clamp technique in its whole-cell con¢guration as described
previously [8]. To prevent ICl;swell contamination with LNCaP cell
endogenous Kþ current [10] we used TEA as a major cation in the
hypotonic solution. The composition of the normal (310 mosmol/l)
and TEA-based hypotonic (200 mosmol/l, hypo-TEA) extracellular
solutions is presented in Table 1. Concentration of Ca2þ chelators
(i.e. BAPTA, EDTA or HEDTA) in the divalent cation-free hypo-
TEA (DVC-free/hypo-TEA) was changed in parallel with D-mannitol
to keep the osmolarity constant. The free Ca2þ concentration in the
presence of Ca2þ chelators was determined with the use of WinMaxc
1.7 program [11]. The resistance of the patch pipettes fabricated from
borosilicate glass capillaries (WPI, Saratoga, FL, USA) varied be-
tween 3 and 5 M6 when ¢lled with the basic intracellular solution
containing (in mM): K-gluconate 100, KCl 50, MgCl2 1, CaCl2 2.6,
HEPES 10, EGTA 8, pH 7.2, osmolarity 290 mosmol/l, estimated
[Ca2þ]free = 1037 M. Changes of the external solutions were carried
out using a multibarrel pu⁄ng micropipette with common out£ow
positioned in close proximity to the cell under investigation.
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3. Results
3.1. The e¡ects of EDTA, BAPTA and HEDTA on ICl;swell in
LNCaP cells
Exposure of LNCaP cells to hypo-TEA (see Table 1) elicits
the development of ICl;swell, which usually reaches its maximal
amplitude within the time span of about 5 min (Fig. 1A). Fig.
1B shows representative recordings of the initial baseline cur-
rent acquired within the ¢rst few seconds after switching to
hypo-TEA and of fully developed ICl;swell in response to the
voltage-clamp pulse that included a linear voltage ramp por-
tion connecting steady O 100 mV levels. The I^V relationship
of ICl;swell derived from the ramp portions of the currents
showed outward recti¢cation typical for ICl;swell and a reversal
potential close to the Cl3 equilibrium (Fig. 1C). Replacing
standard hypo-TEA solution with DVC-free/hypo-TEA (see
Table 1) supplemented with 10 mM EDTA caused almost
instantaneous decrease of ICl;swell, which was much more pro-
nounced at positive membrane potentials (Fig. 1A). The I^V
relationship of the residual current (Fig. 1C) showed the same
reversal potential as the control ICl;swell indicating its Cl3 na-
ture and suggesting that it represents a modi¢ed version of the
original ICl;swell. The modi¢cation primarily consisted in the
voltage-dependent inhibition of ICl;swell, the degree of which
gradually increased from just around 20% at 3100 mV up to
about 50^60% at +50 mV without signi¢cant change from this
level at higher depolarizations (Fig. 1C, inset). Kinetics of
ICl;swell at step pulses to various voltages remained almost
unchanged (Fig. 1D).
To answer the question whether the modi¢cation of ICl;swell
Fig. 1. Extracellular EDTA inhibits ICl;swell in LNCaP cells. A: ICl;swell development in response to hypotonic exposure (at time 0), and the ef-
fect on the current of 10 mM EDTA, (circles) ICl;swell at +20 mV, (squares) at 350 mV; EDTA application is marked by horizontal bar.
B: traces of the baseline current before ICl;swell activation, control ICl;swell, EDTA-inhibited ICl;swell and ICl;swell following EDTA washout; inset:
pulse protocol. C: I^V plots of the control ICl;swell (circles), EDTA-inhibited ICl;swell (squares) and ICl;swell after EDTA washout (line superim-
posed on circles); the I^Vs were derived from ramp recordings of B; inset: voltage dependence of inhibition. D: Representative step pulse-
evoked (see inset) traces of the control ICl;swell (left) and EDTA-inhibited ICl;swell (right); the dotted line superimposed on the control trace at
+100 mV represents the EDTA-modi¢ed trace normalized to the same amplitude at +100 mV demonstrating virtually no di¡erence in the ki-
netics. The data on this ¢gure are for one representative LNCaP cell.
Table 1
Composition of the extracellular solutions (mM)
Normal Hypo-TEA DVC-free/hypo-TEA
NaCl 140 ^ ^
KCl 5 ^ ^
CaCl2 2 2 0
MgCl2 2 2 0
Na2HPO4 0.3 ^ ^
KH2PO4 0.4 ^ ^
NaHCO3 4 ^ ^
Glucose 5 5 5
HEPES 10 10 10
TEA-Cl ^ 80 88
D-Mannitol ^ 14 10^0
Ca2þ chelator ^ ^ 0^40
pH of all solutions was adjusted to 7.2. As Ca2þ chelator BAPTA,
EDTA or HEDTA was used.
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is related to some speci¢c actions of EDTA or is simply due to
its ability to lower the concentration of the divalents we per-
formed similar experiments with the use of two other Ca2þ
chelating agents, BAPTA and HEDTA (N-[2-hydroxyethyl]e-
thylenediaminetriacetic acid, do not mix up with the mono-
protonated form of EDTA designated below as HEDTA33).
Fig. 2A compares the average ICl;swell inhibition at +100 mV
produced by 10 mM EDTA, BAPTA or HEDTA. As one can
see, the percentage of current inhibition was the highest for
BAPTA (67%), followed by EDTA (49%) and then HEDTA
(35%). Theoretical estimates of the free Ca2þ concentration in
the solutions containing 10 mM of the respective chelator
showed that it constitutes 1.2U10311 M for BAPTA,
2.5U10312 M for EDTA and 2.5U10310 M for HEDTA (as-
suming 1036 M of residual Ca2þ in nominally Ca2þ-free so-
lution con¢rmed by our control Fura-2 measurements). Thus,
with any of the three chelators added [Ca2þ]free seems to drop
far below physiologically relevant levels suggesting that ICl;swell
inhibition can hardly be explained by changing [Ca2þ]out.
Moreover, application of DVC-free/hypo-TEA solutions, in
which [Ca2þ]free was bu¡ered at a constant level of 2U1037
M, but with the use of 10 mM BAPTA, EGTA or HEDTA,
produced di¡erential blockade of ICl;swell (Fig. 2A). Again, this
blockade was the strongest for BAPTA (65%) followed by
EDTA (26%) and then HEDTA (7%) ruling out the involve-
ment of Ca2þ. The blockade also did not correlate with the
concentration of free chelator suggesting a great degree of
speci¢city among them.
Given all the data stated above one can assume that direct
speci¢c actions of BAPTA, EGTA and HEDTA on volume-
regulated channels may be responsible for ICl;swell inhibition.
Fig. 2B shows dose^response relationships for the inhibitory
action of all three Ca2þ chelating agents on ICl;swell at
+100 mV. Because the Ca2þ chelator-induced ICl;swell inhibi-
tion was very rapid (see Fig. 1A) we could use in these experi-
ments very brief exposures of the cell to concentrations of
EDTA or HEDTA higher than 10 mM (which could increase
the tonicity of the solution) without fear of invoking the
changes of the current associated with altered tonicity. The
experimental data points were ¢t with Langmuir’s isotherms
(Fig. 2B) to provide the concentration of half-maximal block-
ade (IC50) and the level of maximal blockade (Amax). The
results of the ¢t show that BAPTA is the most e¡ective
ICl;swell inhibitor acting with IC50 = 70 WM and the maximal
Fig. 2. ICl;swell inhibition by Ca2þ chelating agents is unrelated to Ca2þ binding and is pH-dependent. A: ICl;swell blockade at +100 mV by
10 mM of speci¢ed chelator (left) and by the indicated free concentration (mM) of the chelator in a Ca2þ/10 mM chelator mixture resulting in
a ¢xed [Ca2þ]free of 2U1037 M (right); n=6^10. B: Dose^response relationships for the BAPTA-, EDTA- and HEDTA-induced ICl;swell inhibi-
tion with superimposed ¢ts of the data points (n=6^10) by Langmuir’s isotherms (smooth curves) providing indicated values of the maximal
blockade (Amax) and IC50. C: Traces of the control ICl;swell at standard pH 7.3, ICl;swell at increased pH of hypo-TEA to 8.2 and ICl;swell in the
presence of 10 mM EDTA at pH 8.2; inset: pulse protocol. D: Same as in C, but for the decreased pH 6; inset: the di¡erence in ICl;swell
blockade by 10 mM EDTA at pH 6 and pH 8.2 (n=6).
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blockade of Amax = 67%. EDTA was next with IC50 = 1.7 mM
and Amax = 49% followed by HEDTA with IC50 = 23 mM and
Amax = 40%.
3.2. Inhibition of ICl;swell by EDTA is pH-dependent
Free EDTA in the solution exists as negatively charged
partially protonated species with pH-dependent contribution
of various forms [12]. At physiological pH most of it is in
HEDTA33 form with a quite low contribution of the
H2EDTA23 and EDTA43 forms and only negligible traces
of all other ones. The proportion of the EDTA43 form, how-
ever, signi¢cantly increases at the expense of H2EDTA23
form, as pH is made more alkaline, whereas the H2EDTA23
form becomes absolutely dominant at pH6 6. Since VRAC is
an anion channel it seems plausible that the preferential
EDTA-induced blockade of ICl;swell at progressively depolar-
ized membrane potentials is explained by the plugging mech-
anism, in which negatively charged EDTA is driven into the
channel’s outer vestibule due to increasing driving force,
where it can interact with a positively charged locus respon-
sible for anion selectivity, thereby occluding the conducting
pore for the passage of Cl3. If this hypothesis is correct then
the EDTA-induced blockade of ICl;swell should be pH-depen-
dent, increasing at alkaline pH due to an elevated proportion
of the EDTA forms with higher negative charge and vice
versa.
Fig. 2C shows that increasing pH of the hypo-TEA solution
to 8.2 by itself produced an almost twofold enhancement of
ICl;swell ; however, subsequent exposure of the cell to 10 mM
EDTA-supplemented DVC-free/hypo-TEA at this pH inhib-
ited the current by as much as 83.4O 7% (at +100 mV), which
was notably higher than the 49.7O 6.3% observed at normal
pH (Fig. 2A). The reduction of the pH to 6 produced opposite
e¡ects: ¢rst, ICl;swell was suppressed just by transition into
hypo-TEA with pH 6, but subsequent application of 10 mM
EDTA at the same pH caused only 30.7O 4% of current in-
hibition (Fig. 2D). It should be mentioned that at both pHs
free Ca2þ concentration stayed below physiologically relevant
levels (i.e. 1.3U10310 M at pH 6 and 2.9U10313 M at pH 8.2
assuming 1036 M of residual Ca2þ in nominally Ca2þ-free
solution) ruling out Ca2þ as possible active matter in the
described e¡ects.
Thorough inspection of the original ICl;swell recordings also
suggests that at pH 6 and pH 8.2 EDTA induces stronger
blockade at negative voltages (Fig. 2C,D) compared to nor-
mal pH (Fig. 1B). We explain this by the fact that extracel-
lular pH per se is capable of exerting complex e¡ects on
VRAC, which may include modulation of the interaction
with the chelators. Examining the pH e¡ects was beyond
the scope of the present study, however, our preliminary ob-
servations as well as observations of others [13] suggest that
pH in£uences the conductance and the open probability of
volume-regulated channels.
3.3. Inhibition of ICl;swell by Ca
2+ chelating agents is not
cell-speci¢c
After discovering the inhibitory action of Ca2þ chelating
agents on ICl;swell in LNCaP cells we were interested to deter-
mine how universal this e¡ect is with respect to various types
of ion channels as well as with respect to ICl;swell in di¡erent
cell types. Since our data show that BAPTA is the most ef-
fective inhibitor 0.5 mM BAPTA in DVC-free extracellular
solutions was used in this series of experiments. Apart from
LNCaP cells, which in addition to ICl;swell possess a voltage-
gated TEA-sensitive Kþ current [10], we also used rat baso-
philic leukemia (RBL-2H3) cells stably transfected with the
Kv1.3 Kþ channel (kindly provided by Dr. S. Grissmer, Uni-
versity of Ulm, Germany) and also possessing endogenous
ICl;swell [14], and HACaT keratinocytes, which according to
our preliminary observations possess robust ICl;swell as well.
Our experiments showed that neither Kþ current in LNCaP
cells nor Kv1.3-mediated Kþ current in RBL cells was sensi-
tive to 0.5 mM extracellular BAPTA. In contrast, 0.5 mM
BAPTA inhibited ICl;swell in RBL-2H3 cells by 49.7 O 5.3%
(n=6) and ICl;swell in HACaT cells by 35.7O 6.4% (n=4).
These experiments strongly suggest that sensitivity to Ca2þ
chelating agents is likely to be a common feature of all vol-
ume-regulated anion channels irrespective of their phenotypic
representation.
4. Discussion
Ca2þ chelating agents are widely used in biological research
for Ca2þ bu¡ering purposes, and their actions on cellular pro-
cesses have usually been considered as being mediated only
via changing free concentrations of polyvalent cations. How-
ever, there are indications that this may not always be the
case, especially with respect to the relatively novel chelator
BAPTA, which gradually replaces other chelators in most
applications due to its higher speed of Ca2þ binding and bet-
ter pH sensitivity [15]. There is evidence, for instance, that
BAPTA (or its membrane-permeable form BAPTA-AM)
and EGTA are able to directly in£uence Ca2þ-activated Kþ
channels [16] and Ca2þ channels [17,18] in adrenal chroma⁄n
cells and also to inhibit Kþ currents in cerebellar granule
neurons [17,18] suggesting that some channels may have spe-
ci¢c interaction sites with Ca2þ chelating agents.
Our study clearly establishes that various Ca2þ chelating
agents exert di¡erential blocking action on volume-regulated
anion channels underlying ICl;swell. Of the three agents tested ^
BAPTA, EDTA and HEDTA ^ BAPTA appeared to be the
most e¡ective ICl;swell blocker. ICl;swell blockade by all agents
was the strongest at positive voltages when current has an
outward direction associated with inward £ux of negatively
charged Cl3.
Our results on pH dependence of EDTA-induced blockade
of ICl;swell strongly favor the idea that the e⁄cacy of the block-
ade is related to the net negative charge of the free chelator
forms in the solution. This would imply the blocking mecha-
nism, in which the negatively charged extracellular chelator
molecule at membrane potentials that increase the driving
force for its movement in the inward direction would enter
the outer vestibule of VRAC, but because of steric limitation
and/or strong binding would not be able to pass through the
channel plugging it for the passage of Cl3 ions. The constancy
of the ICl;swell reversal potential in the absence and in the
presence of the chelators suggests against their permeation
through the channel. In this case the increasing of negative
charge of the chelator molecule would on the one hand made
it more competitive with Cl3 for the entry into the channel’s
vestibule and on the other hand increase its interaction with
positively charged site(s) of the VRAC channel that underlie
its anion selectivity (e.g. see [19]). Consistent with such block-
ing mechanism, ICl;swell inhibition by extracellular EDTA in-
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creases at more alkaline pHs, when the proportion of free
EDTA forms with higher negative charge goes up. Also con-
sistent with this mechanism is the notably higher potency of
BAPTA in blocking ICl;swell compared to EDTA. Indeed,
BAPTA exhibits much weaker pH sensitivity, and most of it
is represented by the highest negatively charged BAPTA43
form at all pHs above 6 [15].
Finally, our results show that ICl;swell blockade by Ca2þ
chelating agents is not speci¢c to LNCaP cells, but represents
a general phenomenon that is not dependent on the cell type.
Given the possible mechanism of such blockade, we also hy-
pothesize that other types of anion channels may be subjected
to the inhibitory action of Ca2þ chelating agents as well.
Therefore, careful selection of the type and concentration of
Ca2þ chelators to meet speci¢c experimental needs should be
exercised.
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